本页面由Tiger Trade Technology Pte. Ltd.提供服务

Anacor Pharmaceuticals

10.19
0.0000
成交量:- -
成交额:- -
市值:4.03亿
市盈率:31.99
高:10.19
开:10.19
低:10.19
收:10.19
52周最高:10.19
52周最低:9.69
股本:3,953.13万
流通股本:2,626.23万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):0.3185
每股收益(LYR):0.2070
净资产收益率:--
总资产收益率:-1.10%
市净率:-28.77
市盈率(LYR):49.23

数据加载中...

2023/03/06

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/15

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K/A [Amend] - Current report
2022/03/08

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/28

重要事件披露

8-K - Current report
2021/06/01

重要事件披露

8-K - Current report
2021/04/15

重要事件披露

8-K - Current report
2021/03/03

重要事件披露

8-K - Current report
2021/02/26

重要事件披露

8-K - Current report
2021/02/16

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/05

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2016/06/24

交易所摘牌声明